Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

08:34 EDT 30th May 2015 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Suven Lifesciences receives five patents from four countries

Biospectrum With these new patents the company has two granted patents from Israel, 11 from Japan, 15 from China and 21...

Suven secures three product patents for their NCEs in Canada, Japan and Korea

Biospectrum With these new patents, Suven has a total of 18 granted patents from Canada, 16 granted patents from Japan,...

Valencell Expands Robust Portfolio of Critical Patents

Valencell, a leader in performance biometric data sensor technology, today announced it has been granted an additional eight patents by the United States Patent and Trademark Office. The new patents a...

Carestream Awarded 66 U.S. Patents In 2014

Carestream Health was awarded 66 new patents from the U.S. Patent and Trademark Office in 2014 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, reflecting another s...

Ocata gets three new US patents for RPE therapy for macular degenerative diseases

Ocata Therapeutics, a leader in the field of Regenerative Ophthalmology, announced that the US Patent and Trademark Office (USPTO) issued three new US Patents, Nos. 9,040,770, 9,040,039 and 9,040,038,...

Generics makers challenging more patents

In recent years generics makers are becoming bolder and challenging more patents on originator drugs. In fact, litigation regarding patents on pharmaceuticals is on the rise, particularly when it come...

UPDATE 2-EU's top court opens door to some stem cell patents

* Patents allowed if organism can't develop into human being

UPDATE 1-EU's top court opens door to some stem cell patents

* Patents allowed if organism can't develop into human being

Matching PubMed Articles

Patents on Potential Drugs to Treat Alzheimer's Disease: Special Emphasis on Small Peptides.

The primary objective of this article is to review patents and the related scientific work on naturally occurring compounds, heterocyclic compounds and small peptides that are being explored for their...

The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.

Patents have long been considered essential incentives to foster innovation, particularly the development of new prescription drugs, due to the lengthy, costly, and risky nature of the research and de...

Stem Cell Patents after the America Invents Act.

Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to ...

Quantifying innovation in surgery.

The objectives of this study were to assess the applicability of patents and publications as metrics of surgical technology and innovation; evaluate the historical relationship between patents and pub...

Advances and strategies in NADPH oxidase inhibitors and activators patents.

The NADPH oxidase (NOX) enzymes were identified as a family of seven isoforms contributing to the production of reactive oxygen species. During the past 15 years, this class of enzymes has increasingl...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement